Treatment of Cholinergic Urticaria

First-Line Treatment: Antihistamines

The American College of Allergy, Asthma, and Immunology recommends starting with a second-generation non-sedating H1 antihistamine at standard dose, and if symptoms remain inadequately controlled after 2-4 weeks, increase the dose up to 4 times the standard dose 1, 2
Second-generation H1 antihistamines are the mainstay of therapy, with options including cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine, and mizolastine 1
Offer at least two different non-sedating antihistamines to each patient, as individual responses and tolerance vary significantly between agents 1, 2

For urticaria unresponsive to high-dose antihistamines, add omalizumab at a standard starting dose of 300 mg subcutaneously every 4 weeks 1, 2
Allow up to 6 months for patients to respond to omalizumab before considering it a treatment failure 1, 2
If insufficient response at standard dosing, increase to 600 mg every 2 weeks as the maximum recommended dose 1, 3

For patients who do not respond to high-dose antihistamines and omalizumab within 6 months, add cyclosporine to the antihistamine regimen at a dose of up to 5 mg/kg body weight 1, 2, 3
Cyclosporine is effective in approximately 65-70% of patients with severe urticaria 1
Monitor blood pressure and renal function every 6 weeks due to potential nephrotoxicity and hypertension 1, 3

Restrict oral corticosteroids to short courses (3-10 days) for severe acute exacerbations only—they should not be used chronically due to cumulative toxicity 1, 2

Identify and minimize aggravating factors including overheating, stress, alcohol, aspirin, NSAIDs, and codeine 1, 2
Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) can provide symptomatic relief 1, 2

Do not confuse cholinergic urticaria with exercise-induced anaphylaxis, as cholinergic urticaria presents with punctate (1-3 mm diameter) intensely pruritic wheals with erythematous flaring after core body temperature increase, characteristically without vascular collapse 4, 5

A treatment duration of 16 weeks with cyclosporine is superior to 8 weeks for reducing therapeutic failures, as recommended by the British Journal of Dermatology guidelines 6
Long-term oral corticosteroids should not be used in chronic urticaria except in very selected cases under regular specialist supervision, according to the British Journal of Dermatology guidelines 6

Cholinergic urticaria presents with punctate (1-3 mm diameter) intensely pruritic wheals with erythematous flaring after core body temperature increase, characteristically without vascular collapse, as distinguished from exercise-induced anaphylaxis by the Journal of Allergy and Clinical Immunology 7
Exercise-induced anaphylaxis requires emergency management with intramuscular epinephrine and is not responsive to prophylactic antihistamines, as stated by the Journal of Allergy and Clinical Immunology 7
Simply increasing core body temperature does not necessarily produce symptoms of exercise-induced anaphylaxis, unlike cholinergic urticaria, as noted by the Journal of Allergy and Clinical Immunology 7